Nav: Home

Popular hypertension drugs linked to worse heart health in blacks compared to whites

September 15, 2015

Drugs commonly used to treat high blood pressure, and prevent heart attacks and strokes, are associated with significantly worse cardiovascular outcomes in hypertensive African Americans compared to whites, according to a new comparative effectiveness research study led by researchers in the Department of Population Health at NYU Langone Medical Center.

The study, published on September 15 in the Journal of the American College of Cardiology (JACC), is unique, the authors say, in that it evaluates racial differences in cardiovascular outcomes and mortality between hypertensive black and white patients whose treatment was initiated with angiotensin-converting-enzyme (ACE) inhibitors, outside of a clinical trial. ACE inhibitors are one of several classes of drugs commonly prescribed to individuals with hypertension to prevent deaths, heart attack, kidney failure, heart failure and stroke.

Evidence from randomized controlled trials has previously indicated that ACE inhibitors may not provide the same benefits in blacks compared to whites. However, blacks have been largely underrepresented in the majority of these studies, despite the fact they have disproportionately higher rates of hypertension-related morbidity and mortality than other racial and ethnic groups, according to study authors.

"We know what works in clinical trials. But when you go into the real world clinical practice setting, physicians don't often translate that evidence into practice. This is the first study that looks at this issue in a real- world, clinical practice setting," says Gbenga Ogedegbe, MD, MPH, lead author of the study and a professor in the Department of Population Health at NYU Langone Medical Center.

Data for the study came from electronic health records of nearly 60,000 patients who have high blood pressure and received care between 2004-2009 within New York City's Health and Hospital Corporation (HHC). HHC operates all public hospitals and clinics in New York City and is the largest such institution in the country. Approximately 35 percent of patients seen in the HHC system are African American.

The investigators compared rates of all-cause mortality, heart attack, stroke, and congestive heart failure between African American and white patients who were prescribed one of four classes of antihypertensive drugs to treat high blood pressure: ACE inhibitors, beta blockers, calcium-channel blockers, or thiazide-type diuretics. In African Americans, ACE inhibitor use was associated with a statistically significant rate of poorer cardiovascular outcomes (8.7 percent compared to 7.7 percent) but not in whites (6.4 percent compared to 6.74 percent). African Americans were no more likely than whites to have adverse effects linked to use of ACE inhibitors.

The reasons for the noted racial disparity in clinical effectiveness of ACE inhibitor-based regimes between African Americans and whites remain unclear, though the prevailing theory is that blacks are less responsive to antihypertensive treatment with ACE inhibitors. African-Americans are also at greater risk for cardiovascular events than whites.

"The results of this study adds to a growing consensus among physicians that treatment of hypertension in blacks should not be initiated with ACE inhibitors," said Dr. Ogedegbe, director of Division of Health & Behavior and NYU's Center for Healthful Behavior Change.

In January, the Joint National Committee recommended initiating other treatments besides ACE inhibitors in patients of African descent, and there are other guidelines in preparation that can be informed by this study, Dr. Ogedegbe noted.
-end-
Additional authors of the study include other NYU Langone researchers Sripal Bangalore, MD; and Keith Goldfeld, DrPH.

Dr. Ogedegbe was supported by a grant from the National Heart, Lung, and Blood Institute, K24HL111315, in addition to the AHRQ grant R01HS018589. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. The AHRQ did not have any role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, or in the preparation, review, or approval of this manuscript.

About NYU Langone Medical Center

NYU Langone Medical Center, a world-class, patient-centered, integrated academic medical center, is one of the nation's premier centers for excellence in clinical care, biomedical research, and medical education. Located in the heart of Manhattan, NYU Langone is composed of four hospitals--Tisch Hospital, its flagship acute care facility; Rusk Rehabilitation; the Hospital for Joint Diseases, the Medical Center's dedicated inpatient orthopaedic hospital; and Hassenfeld Pediatric Center, a comprehensive pediatric hospital supporting a full array of children's health services across the Medical Center--plus the NYU School of Medicine, which since 1841 has trained thousands of physicians and scientists who have helped to shape the course of medical history. The Medical Center's tri-fold mission to serve, teach, and discover is achieved 365 days a year through the seamless integration of a culture devoted to excellence in patient care, education, and research. For more information, go to http://www.nyulangone.org and interact with us on Facebook, Twitter, and YouTube.

NYU Langone Medical Center / New York University School of Medicine

Related Heart Failure Articles:

Autoimmunity-associated heart dilation tied to heart-failure risk in type 1 diabetes
In people with type 1 diabetes without known cardiovascular disease, the presence of autoantibodies against heart muscle proteins was associated with cardiac magnetic resonance (CMR) imaging evidence of increased volume of the left ventricle (the heart's main pumping chamber), increased muscle mass, and reduced pumping function (ejection fraction), features that are associated with higher risk of failure in the general population
Transcendental Meditation prevents abnormal enlargement of the heart, reduces chronic heart failure
A randomized controlled study recently published in the Hypertension issue of Ethnicity & Disease found the Transcendental Meditation (TM) technique helps prevent abnormal enlargement of the heart compared to health education (HE) controls.
Beta blocker use identified as hospitalization risk factor in 'stiff heart' heart failure
A new study links the use of beta-blockers to heart failure hospitalizations among those with the common 'stiff heart' heart failure subtype.
Type 2 diabetes may affect heart structure and increase complications and death among heart failure patients of Asian ethnicity
The combination of heart failure and Type 2 diabetes can lead to structural changes in the heart, poorer quality of life and increased risk of death, according to a multi-country study in Asia.
Preventive drug therapy may increase right-sided heart failure risk in patients who receive heart devices
Patients treated preemptively with drugs to reduce the risk of right-sided heart failure after heart device implantation may experience the opposite effect and develop heart failure and post-operative bleeding more often than patients not receiving the drugs.
How the enzyme lipoxygenase drives heart failure after heart attacks
Heart failure after a heart attack is a global epidemic leading to heart failure pathology.
Novel heart pump shows superior outcomes in advanced heart failure
Severely ill patients with advanced heart failure who received a novel heart pump -- the HeartMate 3 left ventricular assist device (LVAD) -- suffered significantly fewer strokes, pump-related blood clots and bleeding episodes after two years, compared with similar patients who received an older, more established pump, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.
NSAID impairs immune response in heart failure, worsens heart and kidney damage
Non-steroidal anti-inflammatory drugs, or NSAIDs, are widely known as pain-killers and can relieve pain and inflammation.
Heart cell defect identified as possible cause of heart failure in pregnancy
A new Tel Aviv University study reveals that one of the possible primary causes of heart failure in pregnant women is a functional heart cell defect.
In heart failure, a stronger heart could spell worse symptoms
Patients with stronger-pumping hearts have as many physical and cognitive impairments as those with weaker hearts, suggesting the need for better treatment.
More Heart Failure News and Heart Failure Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.